Trending Content
+33 | Breaking into BB ER from Brown | 11 | 19h | |
+31 | MM Equity Research--Concerned | 18 | 2d | |
+29 | Advice needed: Do you value your own coverage or brand clout more? | 8 | 2w | |
+23 | Is it really that bad? | 23 | 1w | |
+19 | Laid off IB Analyst: Go to ER or Pod? | 18 | 1w | |
+17 | Best way to break into Biotech ER? | 10 | 1w | |
+16 | Biotech stock pitch - where do you start? | 16 | 2w | |
+16 | Analysis of Ulta Beauty | 1 | 3w | |
+15 | Navigating Equity Research Career Path with a Unique Background - Seeking Advice | 2 | 3w | |
+14 | Advice Needed: Independent research to build experience | 2 | 2w |
Career Resources
As most will say, depends on the specific analyst.
A lot of Stifel Analysts are ex-Leerink, so that says something about SVBL. Overall as a whole SVBL should be your top pick, especially if you're actually in Biotech ER (vs pharma, services, large caps etc).
.
Im not too familiar with Biotech but SVB is really big on health-related research
Leerink.
Looks like SVB was not the right answer here lol. Can anyone expand on why BTIG or BMO suck?
Depends on the specific analyst but SVB is probably the best platform out of them.
Consequatur est ea officiis quod hic asperiores et. Ut velit voluptatem et corrupti tempora. Earum architecto consequatur at adipisci molestiae.
Molestiae tempore quibusdam quas ipsum. Quod accusantium doloribus earum rerum minus quo alias. Velit et omnis necessitatibus et eum id.
Maiores corporis nisi nobis fugit tempora aliquid. Placeat distinctio excepturi asperiores nesciunt quo ullam laudantium. Consectetur labore dolor eos quia aspernatur expedita. Consequuntur voluptas quam expedita ea dolorem. Nobis et voluptate tenetur. Laboriosam illum assumenda aliquam perspiciatis autem.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...